Combination therapy with anticoagulants, corticosteroids and intravenous immunoglobulin for women with severe obstetric antiphospholipid syndrome

Clinical and Experimental Rheumatology

Volumn 32, Issue 2, 2014, Pages 299-300

  Watanabe, N ^a   Yamaguchi, K ^a   Motomura, K ^a   Hisano, M ^a   Sago, H ^a   Murashima, A ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; IMMUNOGLOBULIN; PREDNISOLONE; WARFARIN; BETA2 GLYCOPROTEIN 1 ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BRAIN INFARCTION; CASE REPORT; COMBINATION CHEMOTHERAPY; FEMALE; FETUS DEATH; GENITAL BLEEDING; HUMAN; LETTER; LOW DRUG DOSE; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; SPLEEN INFARCTION; THROMBOCYTOPENIA; THROMBOSIS; DISEASE SEVERITY; DOSE RESPONSE;

ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MONITORING, IMMUNOLOGIC; PREGNANCY; PREGNANCY COMPLICATIONS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84904724731     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. MIYAKIS S, LOCKSHIN MD, ATSUMI T et al.: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2. ZIAKAS PD, PAVLOU M, VOULGARELIS M: Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 2010; 115: 1256-62.
3. De JESUS GR, Dos SANTOS FC, OLIVEIRA CS, MENDES-SILVA W, de JESUS NR, LEVY RA: Management of obstetric antiphospholipid syndrome. Curr Rheumatol Rep 2012; 14: 79-86.
4. FISCHER-BETZ R, SPECKER C, BRINKS R, SCHNEIDER M: Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study. Lupus 2012; 21: 1183-9.
5. LE THI THOUONG D, TIEULIE N, COSTEDOAT N et al.: The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 2005; 64: 273-8.
6. SHERER Y, LEVY Y, SHOENFELD Y: Intravenous immunoglobulin therapy of antiphospholipid syndrome. Rheumatology (Oxford) 2000; 39: 421-6.
7. TRIOLO G, FERRANTE A, ACCARDO-PALUMBO A et al.: IVIG in APS pregnancy. Lupus 2004; 13: 731-5.
8. BRAMHAM K, THOMAS M, NELSON-PIERCY C, KHAMASHTA M, HUNT BJ: First-trimester lowdose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. Blood 2011; 117: 6948-51.
9. BATES SM, GREER IA, PABINGER I, SOFAER S, HIRSH J: Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl.): 844S-886S.
10. PAPAIOANNOU GI, SYNGELAKI A, MAIZ N, ROSS JA, NICOLAIDES KH: Ultrasonographic prediction of early miscarriage. Hum Reprod 2011; 26: 1685-92.